"The compounding of knowledge leads to the compounding of wealth."
Shashank Mahajan
Founder, Value Educator
Browse by section
All articlesMid Cap Stocks in India: Company Research and Analysis
Mid cap companies have usually proven their core business and are now moving into larger customers, new products or export markets. The questions shift from survival to scale: how much of the order book is firm, how capacity is being funded, and whether returns hold as the company grows.
Each article here studies one mid cap company from its own filings and management calls, covering the business model, latest results, order book, financials, moat and key risks. The table below links every mid cap company we have covered.
See all 43 companies and articles we have covered ↓
Glenmark: The USD 700 Mn Cancer Deal and Its Brands
Granules India: From Paracetamol to a 65% Gross Margin
Natco Pharma: After Revlimid, 29 Patent Challenges
Shilpa Medicare: Cancer APIs, Films and Biosimilars
Alembic Pharma: US Plants Pay Back, Margin Hits 22.2%
Ajanta Pharma: Branded Generics and a 49% US Jump
All companies and articles in this section
43 research articles, A to Z.
Modern Warfare to Multibaggers
Key Trends. Strategic Shifts. Opportunities Ahead.
Don't Miss This Exclusive Webinar!
Join Value Educator to decode the key trends shaping India's defence sector and learn how to identify tomorrow's potential leaders in the space.
- In-depth research on India's defence sector
- Live Q&A session
- Actionable takeaways for long-term investors
